根据《公司章程》规定，公司董事会由 7 名董事组成，其中非独立董事 4 名，独立董事 3 名。经公司董事会提名委员会对第三届董事会董事候选人资格审核并提出建议，公司于 2023 年 8 月 16 日召开第二届董事会第二十三次会议，审议通过《关于公司董事会换届选举暨提名 第三届董事会非独立董事候选人的议案》及《关于公司董事会换届选举暨提名第三届董事会 独立董事候选人的议案》，同意提名赵文林先生、仝佳奇先生、赵文声先生、赵文浩先生为公 司第三届董事会非独立董事候选人（简历详见附件）；同意提名叶罗沅先生、燕学善先生、阙 占文先生为公司第三届董事会独立董事候选人（简历详见附件），叶罗沅先生为会计专业人士。 其中三位独立董事候选人均已取得独立董事资格证书，叶罗沅先生、燕学善先生已获得 上海证券交易所科创板独立董事视频课程学习证明。阙占文先生承诺在本次提名后，参加上 海证券交易所科创板举办的最近一期独立董事资格培训并取得独立董事学习证明。 根据前述拟任非独立董事和独立董事候选人的个人履历、工作情况等，未发现有相关法 律、行政法规、规范性文件所规定的不得担任公司董事情形，不存在上海证券交易所认定不 适合担任上市公司董事的其 ...

证券代码：688625 证券简称：呈和科技 公告编号： 2023-047 呈和科技股份有限公司 关于召开 2022 年度业绩暨现金分红说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 会议召开时间：2023 年 05 月 26 日(星期五) 下午 14:00-15:00 投资者可于 2023 年 05 月 19 日(星期五) 至 05 月 25 日(星期四)16:00 前登录上证路演中 心网站首页点击"提问预征集"栏目或通过公司邮箱（ir@gchchem.com）进行提问。公司将在 说明会上对投资者普遍关注的问题进行回答。 呈和科技股份有限公司（以下简称"公司"）已于 2023 年 04 月 25 日发布公司《2022 年 年度报告》及《关于公司 2022 年度拟不进行利润分配的公告》，为便于广大投资者更全面深入 地了解公司 2022 年度经营成果、财务状况及利润分配情况，公司计划于 2023 年 05 月 26 日下 午 14:00-15:00 举行 2022 年度业绩暨现金分红说明会，就投 ...

Financial Performance - The company's operating revenue for Q1 2023 was CNY 170,388,735.02, representing a year-on-year increase of 10.26%[3] - The net profit attributable to shareholders was CNY 51,261,195.11, reflecting an increase of 11.06% compared to the same period last year[3] - The net profit after deducting non-recurring gains and losses was CNY 49,844,323.97, which is a 17.84% increase year-on-year[3] - Total operating revenue for Q1 2023 was CNY 170,388,735.02, an increase of 10.5% compared to CNY 154,536,726.63 in Q1 2022[19] - Net profit for Q1 2023 reached CNY 51,261,195.11, representing a 11.5% increase from CNY 46,155,128.91 in Q1 2022[20] - The company reported a total comprehensive income of CNY 50,757,983.81 for Q1 2023, compared to CNY 45,992,410.02 in Q1 2022[20] - Earnings per share for Q1 2023 were CNY 0.38, compared to CNY 0.35 in Q1 2022[21] Research and Development - The total R&D investment amounted to CNY 6,849,918.75, accounting for 4.02% of operating revenue, an increase of 0.19 percentage points[4] - Research and development expenses for Q1 2023 were CNY 6,849,918.75, compared to CNY 5,925,639.61 in Q1 2022, indicating a focus on innovation[19] Assets and Liabilities - The total assets at the end of the reporting period were CNY 2,750,708,165.45, up 15.10% from the end of the previous year[4] - The company's total assets reached RMB 2,750,708,165.45, an increase from RMB 2,389,783,591.35 at the end of 2022, reflecting a growth of approximately 15.1%[13] - The company's total liabilities reached RMB 1,078,659,583.52 in current liabilities, compared to RMB 763,343,359.97, representing an increase of about 41.3%[14] - Total liabilities as of Q1 2023 amounted to CNY 1,641,822,606.63, an increase from CNY 1,332,755,393.54 in the previous year[18] Cash Flow - The net cash flow from operating activities was CNY 28,693,256.02, with improvements in accounts receivable collection contributing to the increase[8] - Cash flow from operating activities for Q1 2023 was CNY 28,693,256.02, a significant improvement from a negative cash flow of CNY -17,631,843.30 in Q1 2022[22] - The net cash flow from investment activities was -138,079,655.68, compared to -107,391,342.01 in the previous year, indicating a decline in investment performance[23] - Cash inflow from financing activities totaled 250,000,000.00, significantly up from 70,000,000.00 in the same quarter last year, reflecting increased borrowing[23] - The net cash flow from financing activities was 246,848,638.92, compared to 29,784,548.60 in the previous year, showing a substantial improvement[23] - The ending balance of cash and cash equivalents was 403,762,272.68, up from 211,620,536.20 in the previous year, indicating a strong liquidity position[23] Shareholder Information - The company had a total of 2,907 common shareholders at the end of the reporting period[10] - The top shareholder, Zhao Wenlin, holds 34.54% of the shares, totaling 46,050,000 shares[10] Other Financial Metrics - The weighted average return on net assets was 4.73%, a decrease of 4.44% compared to the previous year[3] - The company reported a total of CNY 1,416,871.14 in non-recurring gains and losses for the period[7] - The company's cash and cash equivalents amounted to RMB 404,931,027.80, up from RMB 267,852,456.20, representing a significant increase of about 51.1%[13] - Accounts receivable increased to RMB 172,179,737.86 from RMB 142,652,289.34, indicating a rise of approximately 20.8%[13] - The company's short-term borrowings rose to RMB 1,114,789,500.00, compared to RMB 868,108,300.00, marking an increase of around 28.4%[14] - The total current liabilities increased significantly, with contract liabilities rising to RMB 56,785,862.56 from RMB 9,986,028.74, a growth of approximately 469.5%[14] - The company's inventory increased to RMB 72,890,744.31 from RMB 62,978,697.18, reflecting a growth of about 15.5%[13] - The total non-current assets amounted to RMB 1,672,048,581.93, slightly up from RMB 1,626,440,231.38, indicating a growth of approximately 2.8%[14] - The company reported a significant increase in other current assets, which rose to RMB 122,034,784.64 from RMB 30,900,632.40, a growth of approximately 294.5%[13] - The company's goodwill was recorded at RMB 26,359,966.54, indicating the company's ongoing investment in acquisitions and strategic growth initiatives[14] Accounting and Reporting - The company has not adopted new accounting standards for the current year, maintaining consistency in financial reporting[24]

Financial Performance - The company achieved a net profit of RMB 185,330,118.33 for the year 2022, with a 10% statutory surplus reserve of RMB 18,533,011.83 deducted[5]. - The total distributable profit for 2022 amounted to RMB 361,776,445.95 after accounting for the beginning retained earnings of RMB 244,979,364.45 and cash dividends of RMB 50,000,025.00 from the previous year[5]. - The company plans not to distribute cash dividends, issue bonus shares, or increase capital reserves for the year 2022, opting to carry forward the remaining undistributed profits to the next year[5]. - The company's operating revenue for 2022 was ¥694.90 million, representing a 20.60% increase compared to ¥576.22 million in 2021[23]. - Net profit attributable to shareholders for 2022 was ¥195.20 million, up 24.31% from ¥157.03 million in 2021[23]. - The net cash flow from operating activities was ¥296.35 million, a slight increase of 2.22% from ¥289.92 million in 2021[23]. - Total assets grew by 105.91% year-on-year, reaching ¥2.39 billion, driven by the expansion of business scale and increased financial strength[25]. - The basic earnings per share for 2022 was ¥1.46, an increase of 8.15% from ¥1.35 in 2021[24]. - The weighted average return on equity decreased by 5.82 percentage points to 19.86% in 2022 from 25.68% in 2021[24]. - The net profit after deducting non-recurring gains and losses was ¥170.79 million, reflecting a 15.86% increase from ¥147.40 million in 2021[23]. Operational Risks and Governance - The company has detailed various operational risks and corresponding mitigation measures in the report, emphasizing the importance of investor awareness regarding investment risks[4]. - The audit report issued by Lixin Certified Public Accountants (Special General Partnership) was a standard unqualified opinion, ensuring the accuracy of the financial statements[5]. - The company has not faced any non-operational fund occupation by controlling shareholders or related parties during the reporting period[7]. - There were no violations of decision-making procedures regarding external guarantees during the reporting period[7]. - The company has not experienced any situations where more than half of the directors could not guarantee the authenticity, accuracy, and completeness of the annual report[8]. - The report includes a forward-looking statement risk declaration, indicating that future plans and strategies do not constitute a substantive commitment to investors[6]. Research and Development - The R&D investment as a percentage of operating revenue was 4.13%, slightly up from 4.09% in 2021[24]. - Research and development investment amounted to RMB 28.68 million, reflecting a growth of 21.78% compared to the previous year[36]. - The company obtained 13 new invention patents during the reporting period, enhancing its technological capabilities[36]. - The company has focused on core technologies, with advancements in β crystal nucleating agent production and high-purity nucleating agent production technology[72]. - The company has established a strong R&D team and has been actively recruiting top talent from both domestic and international sources[72]. - The company has completed 12 research projects that have passed acceptance by the end of the reporting period[75]. - The company has developed over 200 different types of nucleating agents and composite additives, achieving mass production capabilities[88]. Market Trends and Product Development - The overall demand for petrochemical products is on an upward trend, despite challenges in supply and competition in low-end products[32]. - The company is focusing on innovation and structural changes to create new growth opportunities and maintain low-cost competitive advantages[34]. - The demand for nucleating agents is rapidly increasing, with the global market projected to reach USD 4.45 billion by 2026, driven by applications in packaging, consumer goods, and automotive sectors[53]. - The modified plastics market in China grew from RMB 225 billion in 2018 to RMB 360.2 billion in 2021, with a CAGR of 16.98%, and is expected to reach RMB 415.2 billion in 2022[50]. - The company is the largest domestic producer of nucleating agents and a leading manufacturer of synthetic hydrotalcite and composite additives, with a significant market share in China[64]. Financial Management and Strategy - The company’s financing activities generated a net cash flow of RMB 785.84 million, a significant increase of 92.52%[106]. - The company plans to enhance its product structure by increasing the production of high-value-added products to stabilize operational efficiency[115]. - The company is committed to diversifying its product structure and expanding its business scale through increased R&D and technological innovation, while also seeking external collaborations that align with its core business[171]. - The company aims to enhance its financial performance through strategic planning and effective resource allocation[200]. Corporate Governance - The company’s governance structure includes a board of directors with four specialized committees to ensure professional and efficient decision-making[173]. - The company’s board of directors and management have maintained independence and autonomy in operations, with no significant conflicts of interest reported with controlling shareholders[174]. - The company’s annual report indicates that all resolutions from the shareholders' meetings were approved without any rejections, ensuring transparency in governance[176]. - The audit committee's activities reflect a proactive approach to oversight and compliance with corporate governance standards[198].

2022 年第三季度报告 证券代码：688625 证券简称：呈和科技 呈和科技股份有限公司 2022 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人赵文林、主管会计工作负责人仝佳奇及会计机构负责人（会计主管人员）陈映红 保证季度报告中财务信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期 | | 年初至报告期 末比上年同期 | | --- | --- | --- | --- | --- | | | | 比上年同 | 年初至报告期末 | | | | | 期增减变 | | 增减变动幅度 | | | | 动幅度(%) | | (%) | | 营业收入 | 162,432,444.37 | 19.40 | 492,8 ...

2022 年半年度报告 公司代码：688625 公司简称：呈和科技 呈和科技股份有限公司 2022 年半年度报告 1 / 168 2022 年半年度报告 重要提示 一、本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确 性、完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、重大风险提示 公司已在本报告中详细阐述公司在经营过程中可能面临的各种风险及应对措施，敬请查阅本 报告"第三节管理层讨论与分析"之"风险因素"。敬请投资者注意投资风险。 三、公司全体董事出席董事会会议。 四、本半年度报告未经审计。 五、公司负责人赵文林、主管会计工作负责人仝佳奇及会计机构负责人（会计主管人员）陈映 红声明：保证半年度报告中财务报告的真实、准确、完整。 六、董事会决议通过的本报告期利润分配预案或公积金转增股本预案 无 七、是否存在公司治理特殊安排等重要事项 □适用 √不适用 八、前瞻性陈述的风险声明 √适用 □不适用 本报告中所涉及的未来计划、发展战略等前瞻性描述不构成公司对投资者的实质承诺，敬请 投资者注意投资风险。 九、是否存在被控股股东及其关联方非经营性占用资金情况 ...

2022 年第一季度报告 证券代码：688625 证券简称：呈和科技 呈和科技股份有限公司 2022 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人赵文林、主管会计工作负责人仝佳奇及会计机构负责人（会计主管人员）陈映红保证 季度报告中财务报表信息的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 | | | 单位：元 币种：人民币 | | --- | --- | --- | | | | 本报告期比上年同 | | 项目 | 本报告期 | 期增减变动幅度 | | | | (%) | | 营业收入 | 154,536,726.63 | 26.27 | | 归属于上市公司股东的净利 | 46,155,128.91 | 27.92 | | 润 | | | | 归属于上市公司股东的扣除 ...

2021 年年度报告 公司代码：688625 公司简称：呈和科技 呈和科技股份有限公司 2021 年年度报告 1 / 269 2021 年年度报告 三、 重大风险提示 公司已在本报告中详细阐述公司在经营过程中可能面临的各种风险及应对措施，敬请查阅本 报告"第三节管理层讨论与分析"之"风险因素"。敬请投资者注意投资风险。 四、 公司全体董事出席董事会会议。 五、 立信会计师事务所（特殊普通合伙）为本公司出具了标准无保留意见的审计报告。 六、 公司负责人赵文林、主管会计工作负责人仝佳奇及会计机构负责人（会计主管人员）陈映红 声明：保证年度报告中财务报告的真实、准确、完整。 七、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真实性、准确性、 完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 公司上市时未盈利且尚未实现盈利 □是 √否 公司于2022年4月25日召开第二届董事会第十五次会议，审议通过了《关于2021年度利润分 配预案的议案》，以经审计母公司累计可供分配利润为依据，以未来实施权益 ...

2021 年第三季度报告 证券代码：688625 证券简称：呈和科技 呈和科技股份有限公司 2021 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不 存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务报 表信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、 主要财务数据 主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期比 上年同期增 | | 年初至报告期 末比上年同期 | | --- | --- | --- | --- | --- | | | | | 年初至报告期末 | | | | | 减变动幅度 | | 增减变动幅度 | | | | (%) | | (%) | | 营业收入 | 136,038,797.38 | 26.97 | 398,969,690.87 ...

2021 年半年度报告 公司代码：688625 公司简称：呈和科技 呈和科技股份有限公司 2021 年半年度报告 1 / 149 2021 年半年度报告 重要提示 一、本公司董事会、监事会及董事、监事、高级管理人员保证半年告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、重大风险提示 公司已在本报告中详细阐述公司在经营过程中可能面临的各种风险及应对措施，敬请查阅本 报告"第三节管理层的讨论与分析"之"风险因素"。敬请投资者注意投资风险。 三、公司全体董事出席董事会会议。 四、本半年度报告未经审计。 无 七、是否存在公司治理特殊安排等重要事项 □适用 √不适用 八、前瞻性陈述的风险声明 √适用 □不适用 本报告中所涉及的未来计划、发展战略等前瞻性描述不构成公司对投资者的实质承诺，敬请 投资者注意投资风险。 九、是否存在被控股股东及其关联方非经营性占用资金情况 否 十一、是否存在半数以上董事无法保证公司所披露半年度报告的真实性、准确性和完整性 否 十二、其他 □适用 √不适用 2 / 149 五、公司负责人赵文林、主管会计工作负责人仝佳奇及会计机构负责人（会计主管 ...